SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gray, P.L.
Right arrow Articles by Taberner, P.V.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gray, P.L.
Right arrow Articles by Taberner, P.V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Alterations in dopamine and 5-hydroxytryptamine (5-HT) function during barbiturate dependence and withdrawal in mice

P.L. Gray

Department of Pharmacology, University of Bristol Medical School, University Walk, Bristol BS8 1TD, UK

D. Dawbarn

Department of Pharmacology, University of Bristol Medical School, University Walk, Bristol BS8 1TD, UK

P.V. Taberner

Department of Pharmacology, University of Bristol Medical School, University Walk, Bristol BS8 1TD, UK

Mice were rendered barbiturate-dependent by chronic feeding with barbital-con taining food. Brain dopamine turnover was significantly increased in barbital withdrawal, whereas 5-hydroxytryptamine (5-HT) turnover was significantly decreased. Severity of with drawal was assessed by measuring the convulsions following a dose of 33 mg/kg mer captopropionate (MPA). The neurotoxins 6-hydroxydopamine and 5,6-dihydroxytryptamine as well as metergoline (5 mg/kg) increased the severity of MPA convulsions. Quipazine (20 mg/ kg) attenuated the convulsions. The results are consistent with the hypothesis that diminished 5-HT function may contribute to the barbital withdrawal syndrome. Behavioural responses to serotonergic drugs were enhanced in barbital-dependent mice compared to controls, but [3H]- 5-HT binding to crude membrane fractions was similar in both groups with a single high affinity site.

Journal of Psychopharmacology, Vol. 1, No. 2, 101-108 (1987)
DOI: 10.1177/026988118700100207


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement